Latest News about IONS
Recent news which mentions IONS
Why Cramer Likes Ferguson And Stanley Black & Decker
March 25, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Ionis Pharma Announces Publication Of Positive Donidalorsen Data For Angioedema Attacks
March 17, 2022
Tickers
IONS
From Benzinga
Benzinga's Daily Brief On Trending Tickers For March 11, 2022: Tesla, DTE Energy, Amazon And More
March 11, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For March 2, 2022: VanEck Russia ETF, AMC Entertainment, SoFi Technologies And More
March 02, 2022
From Benzinga
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 25, 2022: GameStop, Tesla, AMD And More
February 25, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 23, 2022: Palantir, GameStop, Tesla, And More
February 23, 2022
From Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 22, 2022: Tesla, GameStop, Lexicon And More
February 22, 2022
From Benzinga
2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul
February 17, 2022
From Motley Fool
Why Investors Aren't Worried About Pfizer's Latest Failure
February 15, 2022
From Motley Fool
What 5 Analyst Ratings Have To Say About Ionis Pharmaceuticals
February 01, 2022
Tickers
IONS
From Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
From Benzinga
Why Pfizer Stock Is Sliding Today
January 31, 2022
From Motley Fool
Why Are Ionis Pharmaceuticals Shares Tanking Today?
January 31, 2022
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 31, 2022: NFLX, BB, IONS, NXPI, EA
January 31, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 31, 2022
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
From Benzinga
From Benzinga
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021
December 14, 2021
From Benzinga
Jim Cramer Shares His Thoughts On Canadian Pacific Railway, Royalty Pharma And More
December 10, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 07, 2021
From Benzinga
Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder
December 07, 2021
From Benzinga
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
From MarketWatch
Pfizer Posts Vupanorsen Data From Mid-Stage Cardiovascular Disease Trial
November 24, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
